Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Swk Holdings Corp. (SWKH:NASDAQ), powered by AI.
Swk Holdings Corp. is currently trading at $15.90. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Swk Holdings Corp. on Alpha Lenz.
Swk Holdings Corp.'s P/E ratio is 14.6.
“Swk Holdings Corp. trades at a P/E of 14.6 (undervalued) with modest ROE of 4.7%. Operating margin of 38.1% indicates strong profitability.”
Ask for details →Swk Holdings Corp. is a specialized finance company focused on the healthcare industry. Its primary function is to provide customized financing solutions to a range of healthcare service providers, pharmaceutical companies, and medical device manufacturers. By offering structured loans and royalty monetization, Swk Holdings Corp. enables healthcare companies to enhance liquidity and manage operational capital effectively. The company plays a pivotal role in the financial market by bridging the gap between traditional lenders and healthcare businesses, often taking positions that emphasize intellectual property and innovative healthcare solutions. Swk Holdings Corp. contributes significantly to the advancement of healthcare finance, impacting sectors such as biotech, pharmaceuticals, and medical devices, thus supporting the growth and development of life-saving products and technologies.
“Swk Holdings Corp. trades at a P/E of 14.6 (undervalued) with modest ROE of 4.7%. Operating margin of 38.1% indicates strong profitability.”
Ask for details →Swk Holdings Corp. (ticker: SWKH) is a company listed on NASDAQ in the Financial Services sector (Asset Management). It has approximately 29 employees. Market cap is $197M.
The current price is $15.9 with a P/E ratio of 14.58x and P/B of 0.68x.
ROE is 4.74% and operating margin is 38.10%. Annual revenue is $45M.